]>
IRCT20200728048243N1 IRCT 2021-05-27 Yazd University of Medical Sciences Evaluation of the effectiveness of ferrous sulfate in preventing recurrence of febrile convulsion Comparison of the effectiveness of two different doses of ferrous sulfate on recurrence rate, one year after the first febrile convulsion(FC) in children one to five years old without iron deficiency anemia 2021-05-26 anticipated 100 Complete https://irct.ir/trial/49983 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: simple randomization, individual, table of random numbers,, Blinding description: The children studied are randomly selected and the therapeutic dose is selected using a random number table. To blind the study, after randomly selecting the samples, the dose of the drug in each group is calculated and prescribed by a pediatrician.The assessor is a pediatric resident and is unaware of the type of group selected and the dose of medication. Participants also become blind to study groups. 2-3 febrile convulsion. Intervention 1: Intervention group 1: receiving ferrous sulfate drops of 1 mg / kg. Intervention 2: Intervention group 2: receiving ferrous sulfate drops of 3 mg / kg. Yes - There is a plan to make this available What will be shared: Only data on age, sex, medication dose, and main outcome (recurrence of febrile seizures) will be shared. When: Access starts 6 months after the results are published To whom: Researchers working in medical universities Conditions: Data requested by other researchers for comparison with similar studies. Where to obtain: Zahra Nafei email adress: z.nafeie@ssu.ac.ir How to obtain: If you need to receive the data, send a message via email so that after the review, it will be provided to the applicant within a maximum period of one month. Comments:
public Saeed Zakerzadeh
No.15, Alley 19, Chamran St.
Yazd Iran (Islamic Republic of) 8915743194 +98 35 3628 4379 s.zakerzadeh@stu.ssu.ac.ir Yazd University of Medical Sciences scientific Nafei Zahra
Central Administration,Bahonar Sq,Yazd University
Yazd Iran (Islamic Republic of) 8916978477 +98 35 3725 8410 z.nafeie@ssu.ac.ir Yazd University of Medical Sciences Iran (Islamic Republic of) The Age of the Child should be in the Range of 12 to 60 Months With first febrile convulsion Normal hemoglobin level and mean corpuscular volume(MCV) 12 months 60 months Both The Patient has Mental Retardation or Developmental Delay The Patient has a history of previous afebrile seizure Existence of Serious Systemic Disease in the Patient(Heart,Liver,Renal Dysfunction ,Rheumatology Disease,Peptic Ulcer,IBD) with acute CNS infection : meningitis , encephalitis R56.0 Febrile convulsions Prevention Prevention Intervention group 1: receiving ferrous sulfate drops of 1 mg / kg Intervention group 2: receiving ferrous sulfate drops of 3 mg / kg Repeated febrile seizures. Timepoint: One year. Method of measurement: observation. Yazd University of Medical Sciences Approved 2019-11-11 Ethics committee of Yazd Shahid Sadoughi University of Medical Sciences Central Administration, Bahonar Sq Yazd Yazd Iran (Islamic Republic of)